Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

[Thomson Reuters ONE] – Landmark BLOCK HF Trial Demonstrates Clinical Benefits of Biventricular Pacing in New Patient Population MINNEAPOLIS – April 10, 2014 – Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view